ReviewPharmaceuticals (Basel, Switzerland)2022

Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A Mimetics.

Holger Heine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.